Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Bladder Cancer

Free Subscription 16.09.2019 1 Ann Surg Oncol 1 Anticancer Res 1 Arch Esp Urol 1 BMC Cancer 1 BMC Urol 1 Cancer Cell Int 1 Chem Commun (Camb) 1 Cochrane Database Syst Rev 1 Endocrinol Diabetes Nutr 1 Eur J Endocrinol 1 Eur Urol 1 Eur Urol Focus 1 Int Immunopharmacol 1 Int J Surg Pathol 2 Int J Urol 2 Investig Clin Urol 1 J Biosci 1 J Patient Rep Outcomes 2 J Urol 1 J Vet Intern Med 1 J Zoo Wildl Med 1 Math Biosci Eng 1 Med Sci Monit 1 Nat Rev Urol 1 Onco Targets Ther 1 Oncogene 1 Oncol Lett 1 Oncotarget 1 Pathol Oncol Res 1 Perm J 1 PLoS One 2 Surg Oncol 1 Turk J Urol 1 Urol Oncol 1 World J Surg Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg Oncol

1. DELL'OGLIO P, Tian Z, Leyh-Bannurah SR, Larcher A, et al
   Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy.
   Ann Surg Oncol. 2019;26:1942-1949.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

2. CHEN M, Tsai YT, Chang WS, Shih LC, et al
   Association of Caspase-8 Genotypes With Bladder Cancer Risk.
   Anticancer Res. 2019;39:4767-4773.
   PubMed     Text format     Abstract available
   
   

   
   Arch Esp Urol

3. ARMAS-ALVAREZ AL, Fernandez-Lopez A, Donate-Moreno MJ, Salinas-Sanchez AS, et al
   [Bladder leiomyomas.]
   Arch Esp Urol. 2019;72:612-615.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

4. YUK HD, Jeong CW, Kwak C, Kim HH, et al
   Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification.
   BMC Cancer. 2019;19:897.
   PubMed     Text format     Abstract available
   
   

   
   BMC Urol

5. VAN HEMELRIJCK M, Sparano F, Josephs D, Sprangers M, et al
   Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review.
   BMC Urol. 2019;19:86.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Cell Int

6. WANG L, Shi J, Huang Y, Liu S, et al
   A six-gene prognostic model predicts overall survival in bladder cancer patients.
   Cancer Cell Int. 2019;19:229.
   PubMed     Text format     Abstract available
   
   

   
   Chem Commun (Camb)

7. DAI Z, Yang L, Li Y, Zhao C, et al
   A portable dual-mode sensor based on a TiO2 nanotube membrane for the evaluation of telomerase activity.
   Chem Commun (Camb). 2019;55:10571-10574.
   PubMed     Text format     Abstract available
   
   

   
   Cochrane Database Syst Rev

8. HWANG EC, Sathianathen NJ, Imamura M, Kuntz GM, et al
   Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
   Cochrane Database Syst Rev. 2019;5:CD013336.
   PubMed     Text format     Abstract available
   
   

   
   Endocrinol Diabetes Nutr

9. KIM JE, Martinez D
   Two uncommon cases of parathyroid hormone-related peptide mediated hypercalcemia in bladder carcinoma.
   Endocrinol Diabetes Nutr. 2019;66:69-70.
   PubMed     Text format    
   
   

   
   Eur J Endocrinol

10. KO SH, Han K, Yun JS, Chung S, et al
    Impact of obesity and diabetes on the incidence of kidney and bladder cancers: a nationwide cohort study.
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0500.R2. doi: 10.1530/EJE-19-0500.
    PubMed     Text format     Abstract available
    
    

    
    Eur Urol

11. SHI MJ, Meng XY, Chen CL, Dyrskjot L, et al
    Reply to Alexander Yang, Vincent L. Cannataro, Jeffrey P. Townsend's Letter to the Editor, re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as, a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Can
    Eur Urol. 2019 Sep 4. pii: S0302-2838(19)30656.
    PubMed     Text format    
    
    

    
    Eur Urol Focus

12. WINOKER JS, Liaw CW, Galsky MD, Wiklund P, et al
    Clinical Complete Response after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Call for Standardized Assessments and Definitions.
    Eur Urol Focus. 2019 Sep 4. pii: S2405-4569(19)30227.
    PubMed     Text format     Abstract available
    
    

    
    Int Immunopharmacol

13. SHARIFI L, Nowroozi MR, Amini E, Arami MK, et al
    A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting.
    Int Immunopharmacol. 2019;76:105880.
    PubMed     Text format     Abstract available
    
    

    
    Int J Surg Pathol

14. NAYAK A, Depasquale B, Vergara N, Guzzo TA, et al
    Villous Adenoma Arising in the Native Bladder Mucosa and the Upper Urinary Tract With Coexisting Neuroendocrine Carcinoma Following Augmentation Cystoplasty.
    Int J Surg Pathol. 2019;27:450-456.
    PubMed     Text format     Abstract available
    
    

    
    Int J Urol

15. CHOO SH, Nishiyama H, Kitamura H, Chen CH, et al
    Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey.
    Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14105.
    PubMed     Text format     Abstract available
    
    
16. NOHARA T, Kato Y, Nakano T, Nakagawa T, et al
    Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14099.
    PubMed     Text format     Abstract available
    
    

    
    Investig Clin Urol

17. PARK HS, Lee S, Lee J, Shin HB, et al
    Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation.
    Investig Clin Urol. 2019;60:396-404.
    PubMed     Text format     Abstract available
    
    
18. SAHIN Y, Yucetas U, Ates HA, Erkan E, et al
    Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response.
    Investig Clin Urol. 2019;60:343-350.
    PubMed     Text format     Abstract available
    
    

    
    J Biosci

19. WU X, Chen H, Zhang G, Wu J, et al
    MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer.
    J Biosci. 2019;44.
    PubMed     Text format     Abstract available
    
    

    
    J Patient Rep Outcomes

20. MICHELS CTJ, Wijburg CJ, Abma IL, Witjes JA, et al
    Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients.
    J Patient Rep Outcomes. 2019;3:62.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

21. ATALA A
    Re: Bladder Cancer Extracellular Vesicles Drive Tumorigenesis by Inducing the Unfolded Protein Response in Endoplasmic Reticulum of Nonmalignant Cells.
    J Urol. 2019 Sep 12:10109701JU00005851520364998.
    PubMed     Text format    
    
    
22. MOREY AF
    Re: Dual Prosthetic Implantation after Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    J Urol. 2019 Sep 13:101097JU0000000000000549. doi: 10.1097/JU.0000000000000549.
    PubMed     Text format    
    
    

    
    J Vet Intern Med

23. LUETHCKE KR, Ekena J, Chun R, Trepanier LA, et al
    Glutathione S-transferase theta genotypes and environmental exposures in the risk of canine transitional cell carcinoma.
    J Vet Intern Med. 2019;33:1414-1422.
    PubMed     Text format     Abstract available
    
    

    
    J Zoo Wildl Med

24. LINNEHAN B, Snyman H, DeLay J, Mareschal A, et al
    URINARY BLADDER TRANSITIONAL CELL CARCINOMA AND CARCINOMATOSIS IN A LINNAEUS'S TWO-TOED SLOTH, CHOLOEPUS DIDACTYLUS.
    J Zoo Wildl Med. 2019;50:278-281.
    PubMed     Text format     Abstract available
    
    

    
    Math Biosci Eng

25. NAVE O, Hareli S, Elbaz M, Iluz IH, et al
    BCG and IL - 2 model for bladder cancer treatment with fast and slow dynamics based on SPVF method-stability analysis.
    Math Biosci Eng. 2019;16:5346-5379.
    PubMed     Text format     Abstract available
    
    

    
    Med Sci Monit

26. LU J, Zhong F, Sun B, Wang C, et al
    Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients.
    Med Sci Monit. 2019;25:6736-6741.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Urol

27. SCHNEIDER AK, Chevalier MF, Derre L
    The multifaceted immune regulation of bladder cancer.
    Nat Rev Urol. 2019 Sep 9. pii: 10.1038/s41585-019-0226.
    PubMed     Text format     Abstract available
    
    

    
    Onco Targets Ther

28. MAN X, Liu T, Jiang Y, Zhang Z, et al
    Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating beta-catenin signaling pathway.
    Onco Targets Ther. 2019;12:6309-6322.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

29. CHEN J, Chou F, Yeh S, Ou Z, et al
    Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Galphai protein/MAPK/MMP9 intracellular signaling.
    Oncogene. 2019 Sep 10. pii: 10.1038/s41388-019-0964.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Lett

30. PIGNOT G, Le Goux C, Vacher S, Schnitzler A, et al
    PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer.
    Oncol Lett. 2019;18:3471-3480.
    PubMed     Text format     Abstract available
    
    

    
    Oncotarget

31. BOURN J, Pandey S, Uddin J, Marnett L, et al
    Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A.
    Oncotarget. 2019;10:5168-5180.
    PubMed     Text format     Abstract available
    
    

    
    Pathol Oncol Res

32. SPACHMANN PJ, Azzolina V, Weber F, Evert M, et al
    Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Pathol Oncol Res. 2019 Sep 10. pii: 10.1007/s12253-019-00745.
    PubMed     Text format     Abstract available
    
    

    
    Perm J

33. MCMULLEN CK, Rosetti MO, Weinmann S, Leo MC, et al
    Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer.
    Perm J. 2019;23.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

34. ZHU Z, Zhao J, Li Y, Pang C, et al
    Prognostic value of preoperative hydronephrosis in patients with bladder cancer undergoing radical cystectomy: A meta-analysis.
    PLoS One. 2019;14:e0222223.
    PubMed     Text format     Abstract available
    
    

    
    Surg Oncol

35. CHOI SY, You D, Hong B, Hong JH, et al
    Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far?
    Surg Oncol. 2019;30:109-116.
    PubMed     Text format     Abstract available
    
    
36. BAO Y, Liu X, Liu Y, Wang S, et al
    Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer.
    Surg Oncol. 2019;30:63-71.
    PubMed     Text format     Abstract available
    
    

    
    Turk J Urol

37. KAPOOR K, Datta C, Pal DK
    Is liquid-based cytology an alternative to conventional cytology for detection of malignant cells in urine of bladder cancer? Eastern Indian prospective observational study.
    Turk J Urol. 2019;45:351-356.
    PubMed     Text format     Abstract available
    
    

    
    Urol Oncol

38. ROGGISCH J, Ecke T, Koch S
    Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer.
    Urol Oncol. 2019 Sep 11. pii: S1078-1439(19)30325.
    PubMed     Text format     Abstract available
    
    

    
    World J Surg Oncol

39. WU L, Yang F, Song L, Xiao Z, et al
    Comparison of intracorporeal and extracorporeal urinary diversions after laparoscopic radical cystectomy in females with bladder cancer.
    World J Surg Oncol. 2019;17:161.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: